Novartis | Beban Penjualan Dan Administrasi


Selling And Administration Expenses Perubahan
Abbvie ABBV:US $ 3.13B 73M
Alcon AG ALC:SW 773.47M 39.47M
Amgen AMGN:US $ 1.33B 99M
AstraZeneca AZN:LN 3.27B 209M
Bayer BAYN:GR 4.47B 527M
Biogen BIIB:US $ 572.6M 62.3M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Eli Lilly And LLY:US $ 1.63B 67.2M
Fresenius FRE:GR 1.63B 154M
Fresenius Medical Care FME:GR 969M 97.76M
Galapagos GLPG:NA 71.67M 9.33M
Genmab GEN:DC 633M 181M
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 1.96B 726M
Hikma Pharmaceutical HIK:LN 256M 0
Johnson & Johnson JNJ:US $ 6.23B 288M
Merck MRK:GR 1.52B 151M
Merk MRK:US $ 2.42B 118M
Novartis NOVN:VX 3.59B 91M
Novartis NVS:US 3.59B 91M
Orion ORNBV:FH 64.7M 3.4M
Pfizer PFE:US $ 3.2B 506M
Philips PHIA:NA 1.26B 38M
Recordati REC:IM 145.08M 23.35M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M



Novartis Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Aug 2022.